Severe nausea and vomiting of pregnancy: should it be treated with appropriate pharmacotherapy?

  • Gadsby R
  • Barnie-Adshead T
N/ACitations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Key content: • Severe nausea and vomiting occurs in up to 30% of pregnant women and it can cause significant morbidity. • There are over 25 000 admissions per year for hyperemesis gravidarum in England. • Safe, effective treatments for severe nausea and vomiting of pregnancy are available. • Early treatment is important to prevent the development of hyperemesis gravidarum. • Treatment algorithms have been developed in other countries. Learning objectives: • To recognise that severe nausea and vomiting of pregnancy often occurs after midday, so the term 'morning sickness' is inappropriate. • To increase knowledge of the evidence for safe, effective treatment of the condition. • To understand that effective management is important. Ethical issues: • There are concerns about teratogenicity when prescribing pharmacological therapy: severe pregnancy sickness may, therefore, go untreated. • Lack of treatment may be associated with increased admissions for hyperemesis gravidarum.

Cite

CITATION STYLE

APA

Gadsby, R., & Barnie-Adshead, T. (2011). Severe nausea and vomiting of pregnancy: should it be treated with appropriate pharmacotherapy? The Obstetrician & Gynaecologist, 13(2), 107–111. https://doi.org/10.1576/toag.13.2.107.27654

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free